Author | Country | Design | ERAS group/control group | Operation | Age (year) | PSA (ng/ml) | BMI | |||
---|---|---|---|---|---|---|---|---|---|---|
ERAS group | Control group | ERAS group | Control group | ERAS group | Control group | |||||
Magheli et al. [12] | Germany | RCT | 25/25 | LRP | 61.8 ± 4.7 | 61.9 ± 7 | 7.2 ± 4.9 | 10.3 ± 8.6 | / | / |
Ren et al. [15] | China | RCT | 9/9 | LRP | 69.2 | 12 | / | / | ||
Huang et al. [10] | China | Retrospective cohort study | 36/37 | RALP | 62.1 ± 6.9 | 63.5 ± 7.4 | 13.44 ± 8.01 | 15.4 ± 10.59 | 23.1 ± 2.1 | 23.5 ± 2.2 |
Pan and Li [14] | China | RCT | 50/50 | LRP | 69.3 ± 7.32 | / | / | / | / | |
Yu and Wang [16] | China | RCT | 26/25 | RALP | 67.65 ± 7.37 | 72.00 ± 6.07 | 31.55 ± 22.57 | 31.35 ± 31.46 | 21.88 ± 2.49 | 20.84 ± 3.15 |
Dong et al. [13] | China | RCT | 109/95 | RALP/LRP | 66.76 ± 5.83 | 66.95 ± 5.70 | / | / | 22.39±1.47 | 22.32 ± 1.54 |
Lin et al. [11] | China | Retrospective cohort study | 124/164 | LRP | 70.9 ± 3.6 | 70 ± 4.3 | 44.5 ± 22.3 | 36.8 ± 23.2 | 20.3 ± 1.5 | 20.4 ± 1.4 |